2021 annual financial data
Ovid Therapeutics 2021 Operating margin
Direct answer
Operating margin was 59.61%.
Operating income was 124.21M USD and net income was 122.83M USD.
Operating cash flow was 118.61M USD.
Get free Ovid Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 208.38M USD
- Operating income
- 124.21M USD
- Net income
- 122.83M USD
- Operating cash flow
- 118.61M USD